There is a widely acknowledged association between insulin resistance and obesity/type 2 Diabetes (T2DM) [2], and insulin sensitizing treatments have proved effective in preventing diabetes and inducing weight loss [3,4]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.